Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Axsome Therapeutics, Inc

AXSM Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of AXSM by members of U.S. Congress

AXSM Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
AXSM Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AXSM Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in AXSM holdings by institutional investors

Quarterly net insider trading by AXSM's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for AXSM

Quiver Logo

No former government officials on record as having lobbied for AXSM

Revolving Door Dashboard

AXSM Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

AXSM Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
AXSM Income Statement
AXSM Balance Sheet
AXSM Cash Flow
U.S. Patents

New AXSM patent grants

  • Patent Title: Pharmaceutical compositions comprising meloxicam Jul. 28, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jul. 21, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam May. 05, 2026
  • Patent Title: Use of reboxetine to treat narcolepsy May. 05, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 28, 2026
  • Patent Title: (s)-2-((s)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine Mar. 03, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam Feb. 17, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam Feb. 17, 2026
  • Patent Title: Methods of treating migraines with a combination of a meloxicam and a rizatriptan Feb. 10, 2026
  • Patent Title: Pharmaceutical compositions comprising meloxicam Dec. 02, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 25, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 18, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 18, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 18, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 18, 2025
  • Patent Title: Use of reboxetine to treat narcolepsy Oct. 21, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jul. 29, 2025
  • Patent Title: Pharmaceutical compositions comprising bupropion and cysteine Jul. 15, 2025
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jul. 15, 2025
  • Patent Title: Pharmaceutical compositions comprising a tolfenamic acid Apr. 08, 2025
  • Patent Title: Use of reboxetine to treat narcolepsy Mar. 11, 2025
  • Patent Title: Pharmaceutical compositions comprising bupropion and cysteine Dec. 03, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Oct. 29, 2024
  • Patent Title: Use of reboxetine to treat narcolepsy Oct. 15, 2024
  • Patent Title: Dosage forms and methods for enantiomerically enriched or pure bupropion Oct. 01, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jun. 11, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jun. 04, 2024
  • Patent Title: Compositions for delivery of reboxetine Apr. 16, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 02, 2024
  • Patent Title: Reboxetine to treat narcolepsy Jan. 30, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Jan. 09, 2024
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 28, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 28, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 07, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Oct. 31, 2023
  • Patent Title: Dosage forms and methods for enantiomerically enriched or pure bupropion Oct. 17, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Sep. 19, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Aug. 29, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Aug. 01, 2023
  • Patent Title: Dosage forms and methods for enantiomerically enriched or pure bupropion May. 30, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 18, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 04, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 04, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Apr. 04, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Mar. 21, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Mar. 14, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Feb. 07, 2023
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 29, 2022
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 22, 2022
  • Patent Title: Pharmaceutical compositions comprising meloxicam Nov. 21, 2017
Government Contracts

Estimated quarterly amount awarded to AXSM from public contracts

AXSM News

Recent insights relating to AXSM

CNBC Recommendations

Recent picks made for AXSM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AXSM

AXSM Analyst Ratings

AXSM Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AXSM Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AXSM stock a Buy, Sell, or Hold?

  • What is the price target for $AXSM stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AXSM Top Shareholders
Shareholder
Shares Held
AXSM Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AXSM stock?

  • Who owns the most shares of $AXSM stock?

  • What funds own $AXSM stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AXSM Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AXSM Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About AXSM

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

  • Address New York, NY
  • Market Cap 10.3 billion
  • Employees 925
  • Industrial Classification Pharmaceutical Preparations

Axsome Therapeutics, Inc (AXSM) Historical Stock Prices

Axsome Therapeutics, Inc (AXSM) closed at $193.45 on September 23, 2026. Over the past year its adjusted close ranged from $116.01 to $255.17. Daily prices go back to November 19, 2015, 2,725 trading days in all.

  • 1 month-5.82%
  • 3 months-18.69%
  • Year to date+5.92%
  • 1 year+63.68%
  • 3 years+163.27%
  • 5 years+479.19%
  • Max+2,113.39%
See every congressional and insider trade on the AXSM price chart

Quiver Premium charts AXSM's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 204.00 204.69 189.05 193.45 193.45 912,995
Sep 22, 2026 205.68 207.01 202.52 203.10 203.10 299,785
Sep 21, 2026 208.17 210.85 203.38 205.49 205.49 543,471
Sep 18, 2026 212.05 213.26 206.92 207.78 207.78 869,320
Sep 17, 2026 215.59 216.47 208.63 214.28 214.28 681,463
Sep 16, 2026 202.95 214.63 201.94 211.97 211.97 644,995
Sep 15, 2026 215.02 215.02 203.78 204.07 204.07 591,345
Sep 14, 2026 221.93 223.29 216.00 216.58 216.58 718,804
Sep 11, 2026 212.71 229.62 212.44 220.75 220.75 1,228,406
Sep 10, 2026 210.63 211.65 208.01 211.12 211.12 526,389
Sep 9, 2026 207.97 211.22 205.75 210.63 210.63 428,389
Sep 8, 2026 205.00 210.85 202.00 207.82 207.82 385,778
Sep 4, 2026 207.01 208.51 205.49 206.68 206.68 438,242
Sep 3, 2026 209.32 210.59 206.60 208.35 208.35 558,821
Sep 2, 2026 203.11 210.55 201.54 209.92 209.92 608,189
Sep 1, 2026 199.71 205.94 199.71 202.83 202.83 656,301
Aug 31, 2026 199.00 200.74 197.05 198.52 198.52 503,716
Aug 28, 2026 205.70 205.70 199.00 199.02 199.02 441,308
Aug 27, 2026 205.00 208.25 203.71 206.27 206.27 586,267
Aug 26, 2026 204.48 210.68 203.70 207.15 207.15 378,908
Aug 25, 2026 207.58 209.53 200.19 205.48 205.48 731,550
Aug 24, 2026 207.00 208.09 205.09 205.40 205.40 293,225
Aug 21, 2026 207.22 210.87 206.50 207.77 207.77 734,950
Aug 20, 2026 216.50 217.85 206.25 208.03 208.03 620,926
Aug 19, 2026 218.93 222.46 216.72 218.20 218.20 572,114
Aug 18, 2026 215.93 220.00 214.39 215.69 215.69 506,353
Aug 17, 2026 212.01 216.96 211.44 216.27 216.27 511,870
Aug 14, 2026 211.00 216.30 208.95 213.67 213.67 476,327
Aug 13, 2026 215.76 221.55 212.63 213.68 213.68 705,315
Aug 12, 2026 216.80 218.75 213.15 214.66 214.66 1,240,601
Aug 11, 2026 222.33 223.04 215.35 215.77 215.77 834,377
Aug 10, 2026 215.88 223.40 210.00 220.89 220.89 1,398,625
Aug 7, 2026 210.13 214.39 208.61 212.74 212.74 1,024,525
Aug 6, 2026 212.73 216.56 209.97 210.13 210.13 397,250
Aug 5, 2026 214.49 218.12 209.26 212.85 212.85 665,357
Aug 4, 2026 212.81 214.89 210.13 212.17 212.17 473,522
Aug 3, 2026 215.50 216.25 206.94 211.04 211.04 962,867
Jul 31, 2026 234.46 235.10 217.64 217.99 217.99 782,168
Jul 30, 2026 229.25 235.21 223.71 234.64 234.64 714,361
Jul 29, 2026 233.96 235.91 227.00 227.42 227.42 523,066
Jul 28, 2026 241.95 242.10 232.34 234.20 234.20 404,143
Jul 27, 2026 240.43 245.50 237.08 238.37 238.37 773,053
Jul 24, 2026 240.92 242.96 237.78 241.00 241.00 461,989
Jul 23, 2026 239.00 244.60 237.00 241.53 241.53 500,364
Jul 22, 2026 235.69 240.73 233.73 239.62 239.62 648,276
Jul 21, 2026 225.80 237.35 221.24 236.95 236.95 993,638
Jul 20, 2026 229.74 232.99 221.21 221.64 221.64 776,410
Jul 17, 2026 233.62 237.36 228.12 230.00 230.00 878,315
Jul 16, 2026 235.92 240.86 233.22 237.04 237.04 639,658
Jul 15, 2026 232.58 237.98 229.64 237.53 237.53 838,870
Jul 14, 2026 229.02 236.01 226.67 235.26 235.26 482,756
Jul 13, 2026 230.15 231.81 224.70 228.28 228.28 843,010
Jul 10, 2026 248.32 249.11 230.14 233.80 233.80 804,667
Jul 9, 2026 245.13 249.55 243.72 248.95 248.95 621,739
Jul 8, 2026 249.36 252.53 245.40 245.57 245.57 769,421
Jul 7, 2026 242.31 252.60 239.86 249.76 249.76 1,055,991
Jul 6, 2026 245.40 251.25 239.02 242.60 242.60 842,382
Jul 2, 2026 242.49 245.20 238.33 244.31 244.31 854,306
Jul 1, 2026 244.77 247.64 237.64 240.66 240.66 977,820
Jun 30, 2026 245.62 248.62 240.38 244.77 244.77 1,195,972
Jun 29, 2026 244.08 248.15 236.47 241.12 241.12 1,357,612
Jun 26, 2026 239.88 247.50 238.25 241.67 241.67 7,350,038
Jun 25, 2026 238.83 244.67 236.59 237.33 237.33 1,384,275
Jun 24, 2026 245.60 246.76 236.44 237.92 237.92 1,126,374
Jun 23, 2026 247.85 252.03 241.56 241.97 241.97 1,312,955
Jun 22, 2026 249.05 253.00 245.94 247.85 247.85 814,132
Jun 18, 2026 255.62 260.19 247.34 250.50 250.50 770,864
Jun 17, 2026 251.13 254.84 248.64 252.16 252.16 519,447
Jun 16, 2026 255.03 255.03 248.08 251.91 251.91 684,263
Jun 15, 2026 253.42 255.09 251.14 253.40 253.40 628,429
Jun 12, 2026 253.04 257.93 253.04 255.17 255.17 441,738
Jun 11, 2026 249.12 257.44 247.69 253.77 253.77 787,532
Jun 10, 2026 246.18 256.00 245.11 246.34 246.34 741,310
Jun 9, 2026 237.21 246.41 236.38 245.64 245.64 918,050
Jun 8, 2026 234.00 239.24 233.29 235.14 235.14 548,893
Jun 5, 2026 231.21 242.41 228.24 232.32 232.32 1,118,650
Jun 4, 2026 233.80 236.46 229.07 231.48 231.48 557,783
Jun 3, 2026 225.21 233.56 217.15 233.49 233.49 783,788
Jun 2, 2026 225.89 228.34 218.56 222.16 222.16 603,813
Jun 1, 2026 233.50 233.50 227.64 230.25 230.25 499,180
May 29, 2026 231.53 236.50 230.01 234.48 234.48 913,891
May 28, 2026 234.22 236.68 231.38 232.83 232.83 472,341
May 27, 2026 235.00 236.69 231.25 234.52 234.52 708,938
May 26, 2026 236.79 238.56 233.33 234.20 234.20 646,604
May 22, 2026 235.00 236.84 232.02 235.97 235.97 674,622
May 21, 2026 230.00 234.79 224.00 233.64 233.64 590,697
May 20, 2026 228.15 232.39 226.50 230.62 230.62 646,757
May 19, 2026 227.48 229.00 223.72 226.67 226.67 510,292
May 18, 2026 229.17 232.00 225.41 227.40 227.40 464,521
May 15, 2026 229.71 230.50 225.71 227.72 227.72 549,548
May 14, 2026 234.46 235.00 227.84 232.27 232.27 572,510
May 13, 2026 224.24 235.91 223.75 235.32 235.32 815,619
May 12, 2026 217.34 224.75 214.31 224.03 224.03 633,376
May 11, 2026 216.08 217.60 213.19 216.47 216.47 738,195
May 8, 2026 220.56 223.43 216.77 217.38 217.38 574,232
May 7, 2026 220.01 221.00 216.41 220.22 220.22 919,211
May 6, 2026 221.71 227.45 220.85 222.63 222.63 559,911
May 5, 2026 226.10 231.00 222.33 223.06 223.06 1,019,974
May 4, 2026 212.00 234.29 208.50 223.70 223.70 2,507,135
May 1, 2026 207.23 209.14 198.02 206.53 206.53 1,636,390
Apr 30, 2026 184.28 217.00 183.86 207.75 207.75 2,798,891
Apr 29, 2026 182.49 185.71 180.00 183.95 183.95 760,718
Apr 28, 2026 188.59 190.10 181.66 185.00 185.00 664,861
Apr 27, 2026 186.51 193.49 186.51 187.40 187.40 919,877
Apr 24, 2026 181.57 191.14 180.90 185.96 185.96 527,083
Apr 23, 2026 186.70 186.99 182.02 182.72 182.72 418,909
Apr 22, 2026 183.99 186.59 180.75 186.42 186.42 614,565
Apr 21, 2026 188.19 188.84 181.43 182.97 182.97 717,382
Apr 20, 2026 188.33 191.00 187.00 188.69 188.69 525,107
Apr 17, 2026 186.91 190.23 185.77 188.99 188.99 767,417
Apr 16, 2026 182.85 184.96 180.22 184.19 184.19 410,134
Apr 15, 2026 184.18 185.05 179.57 184.18 184.18 540,440
Apr 14, 2026 179.77 184.22 178.33 184.18 184.18 820,763
Apr 13, 2026 177.10 182.50 175.44 178.33 178.33 549,583
Apr 10, 2026 181.00 181.99 177.00 178.11 178.11 560,260
Apr 9, 2026 173.05 180.71 172.02 178.90 178.90 986,017
Apr 8, 2026 172.00 174.29 167.14 173.19 173.19 524,924
Apr 7, 2026 167.73 169.28 165.17 168.74 168.74 401,488
Apr 6, 2026 167.90 170.01 167.07 169.74 169.74 337,510
Apr 2, 2026 171.22 171.22 166.65 168.50 168.50 617,093
Apr 1, 2026 170.48 174.81 169.88 171.78 171.78 604,270
Mar 31, 2026 160.20 171.60 159.92 169.02 169.02 677,100
Mar 30, 2026 155.63 160.97 155.00 160.50 160.50 517,975
Mar 27, 2026 163.89 163.89 155.56 156.35 156.35 680,802
Mar 26, 2026 160.05 165.69 159.06 164.26 164.26 304,440
Mar 25, 2026 160.74 163.48 160.60 161.78 161.78 434,892
Mar 24, 2026 155.90 158.97 152.28 158.75 158.75 1,251,882
Mar 23, 2026 156.98 159.40 153.46 156.84 156.84 409,885
Mar 20, 2026 159.64 160.03 155.42 156.92 156.92 849,314
Mar 19, 2026 157.41 159.53 156.40 158.88 158.88 454,761
Mar 18, 2026 160.72 160.72 157.28 157.87 157.87 464,673
Mar 17, 2026 158.51 161.36 157.90 161.17 161.17 481,511
Mar 16, 2026 157.50 159.15 155.89 158.23 158.23 510,708
Mar 13, 2026 154.55 157.75 153.66 156.08 156.08 862,767
Mar 12, 2026 157.98 158.88 153.37 154.12 154.12 769,035
Mar 11, 2026 164.99 165.16 158.60 159.50 159.50 656,790
Mar 10, 2026 164.75 169.11 164.45 166.34 166.34 423,901
Mar 9, 2026 162.50 164.99 160.00 164.49 164.49 425,566
Mar 6, 2026 159.80 163.01 158.41 162.33 162.33 386,982
Mar 5, 2026 162.11 163.80 159.66 161.46 161.46 496,030
Mar 4, 2026 164.02 166.09 163.22 164.08 164.08 428,787
Mar 3, 2026 164.77 167.72 163.18 164.05 164.05 617,604
Mar 2, 2026 162.06 168.00 161.18 166.38 166.38 566,830
Feb 27, 2026 163.13 165.56 162.38 163.89 163.89 613,788
Feb 26, 2026 163.85 163.85 160.10 163.19 163.19 1,002,849
Feb 25, 2026 170.00 170.75 163.16 164.22 164.22 872,995
Feb 24, 2026 175.01 175.29 166.88 169.95 169.95 1,069,111
Feb 23, 2026 176.42 181.84 166.32 174.76 174.76 863,542
Feb 20, 2026 186.00 186.00 181.50 183.72 183.72 573,877
Feb 19, 2026 184.74 186.34 181.83 186.18 186.18 397,545
Feb 18, 2026 182.60 186.04 182.60 184.74 184.74 495,384
Feb 17, 2026 183.65 184.99 181.17 183.30 183.30 569,671
Feb 13, 2026 183.35 186.62 180.40 181.21 181.21 363,961
Feb 12, 2026 186.97 186.97 182.69 182.94 182.94 229,753
Feb 11, 2026 184.12 187.18 181.00 186.21 186.21 374,843
Feb 10, 2026 183.09 185.51 182.71 184.30 184.30 468,306
Feb 9, 2026 183.02 184.06 180.00 183.22 183.22 309,014
Feb 6, 2026 181.80 184.09 178.00 182.55 182.55 661,789
Feb 5, 2026 185.42 188.44 180.02 180.84 180.84 891,461
Feb 4, 2026 186.68 188.10 184.55 185.54 185.54 623,354
Feb 3, 2026 188.25 190.76 185.73 187.35 187.35 910,842
Feb 2, 2026 184.38 187.19 183.74 185.88 185.88 581,083
Jan 30, 2026 185.55 188.00 180.56 184.25 184.25 745,829
Jan 29, 2026 183.24 187.10 181.13 185.26 185.26 499,929
Jan 28, 2026 187.69 189.01 184.00 185.17 185.17 421,546
Jan 27, 2026 185.42 189.95 185.26 188.02 188.02 403,432
Jan 26, 2026 184.37 188.01 184.37 184.52 184.52 335,409
Jan 23, 2026 186.43 187.45 184.90 185.96 185.96 426,662
Jan 22, 2026 189.00 191.50 185.05 186.98 186.98 621,515
Jan 21, 2026 183.98 189.34 183.69 189.10 189.10 1,389,472
Jan 20, 2026 178.00 185.98 175.00 184.50 184.50 1,280,877
Jan 16, 2026 175.71 178.56 172.05 177.27 177.27 618,951
Jan 15, 2026 177.01 177.01 173.32 174.14 174.14 666,504
Jan 14, 2026 173.66 179.00 172.73 177.01 177.01 457,427
Jan 13, 2026 177.91 177.95 173.67 174.33 174.33 613,361
Jan 12, 2026 172.50 179.45 170.06 176.82 176.82 1,167,297
Jan 9, 2026 169.10 173.78 168.51 169.38 169.38 793,800
Jan 8, 2026 168.97 170.59 165.75 167.55 167.55 808,898
Jan 7, 2026 171.90 173.73 168.02 170.69 170.69 814,991
Jan 6, 2026 173.00 176.00 170.30 171.88 171.88 791,670
Jan 5, 2026 178.88 179.02 168.58 171.49 171.49 1,057,288
Jan 2, 2026 183.33 183.33 175.02 178.69 178.69 1,431,598
Dec 31, 2025 158.49 184.40 158.49 182.64 182.64 3,052,560
Dec 30, 2025 150.97 153.02 148.13 148.79 148.79 519,474
Dec 29, 2025 152.00 153.15 150.01 150.68 150.68 551,171
Dec 26, 2025 153.76 154.22 151.27 152.05 152.05 463,174
Dec 24, 2025 154.74 155.84 153.50 153.64 153.64 145,111
Dec 23, 2025 155.36 158.56 152.41 154.19 154.19 469,884
Dec 22, 2025 152.65 156.39 152.65 154.70 154.70 606,846
Dec 19, 2025 147.18 154.49 147.18 152.65 152.65 975,307
Dec 18, 2025 148.19 149.00 145.88 147.00 147.00 392,566
Dec 17, 2025 146.84 148.87 145.71 148.00 148.00 421,912
Dec 16, 2025 146.76 148.21 145.07 146.87 146.87 303,813
Dec 15, 2025 148.36 149.13 145.10 146.24 146.24 364,590
Dec 12, 2025 148.67 148.85 144.13 148.17 148.17 554,080
Dec 11, 2025 149.75 150.00 146.34 148.75 148.75 276,799
Dec 10, 2025 145.12 149.87 144.97 149.26 149.26 406,310
Dec 9, 2025 146.99 148.54 144.00 145.22 145.22 440,003
Dec 8, 2025 150.77 151.51 147.47 147.56 147.56 631,396
Dec 5, 2025 148.00 151.63 147.60 149.22 149.22 492,343
Dec 4, 2025 147.63 149.93 147.50 148.04 148.04 358,673
Dec 3, 2025 142.89 148.72 142.62 147.81 147.81 616,863
Dec 2, 2025 149.24 149.25 141.69 142.09 142.09 785,282
Dec 1, 2025 150.00 151.58 148.55 149.03 149.03 504,997
Nov 28, 2025 151.77 152.76 150.06 151.50 151.50 189,517
Nov 26, 2025 150.01 152.00 147.97 150.98 150.98 541,258
Nov 25, 2025 152.13 152.94 150.00 150.36 150.36 359,541
Nov 24, 2025 148.86 151.38 148.02 151.20 151.20 542,877
Nov 21, 2025 143.90 149.76 142.51 149.44 149.44 531,766
Nov 20, 2025 148.78 149.50 142.91 143.31 143.31 821,306
Nov 19, 2025 146.98 149.24 144.51 146.77 146.77 492,280
Nov 18, 2025 145.38 149.46 143.68 147.48 147.48 798,786
Nov 17, 2025 139.53 146.68 138.90 145.56 145.56 877,074
Nov 14, 2025 137.03 141.99 136.00 139.69 139.69 401,439
Nov 13, 2025 140.23 140.90 136.40 137.40 137.40 507,352
Nov 12, 2025 140.35 144.15 139.65 140.86 140.86 677,452
Nov 11, 2025 137.21 142.19 137.00 139.61 139.61 551,832
Nov 10, 2025 138.97 140.38 136.94 137.80 137.80 530,613
Nov 7, 2025 139.50 139.50 134.49 138.15 138.15 459,009
Nov 6, 2025 135.66 141.36 133.01 139.41 139.41 572,925
Nov 5, 2025 134.66 135.80 131.49 135.69 135.69 577,471
Nov 4, 2025 134.01 136.10 131.51 134.93 134.93 725,848
Nov 3, 2025 123.90 137.85 123.50 135.75 135.75 1,238,888
Oct 31, 2025 132.21 135.72 132.00 134.99 134.99 508,233
Oct 30, 2025 132.66 136.24 131.01 133.15 133.15 405,250
Oct 29, 2025 133.10 134.91 129.40 133.33 133.33 406,691
Oct 28, 2025 133.55 136.23 132.61 133.51 133.51 515,326
Oct 27, 2025 130.20 134.99 130.20 134.68 134.68 454,852
Oct 24, 2025 127.28 130.63 127.17 129.55 129.55 530,569
Oct 23, 2025 130.20 130.40 126.80 127.06 127.06 294,252
Oct 22, 2025 130.51 131.75 127.49 129.72 129.72 395,848
Oct 21, 2025 131.25 131.80 128.48 131.39 131.39 342,014
Oct 20, 2025 129.71 134.36 126.30 131.60 131.60 814,640
Oct 17, 2025 124.18 128.22 124.18 127.94 127.94 346,606
Oct 16, 2025 129.91 130.81 124.02 125.00 125.00 495,705
Oct 15, 2025 123.42 130.35 123.42 129.58 129.58 686,604
Oct 14, 2025 120.65 124.39 120.12 123.52 123.52 292,015
Oct 13, 2025 122.04 122.27 119.20 121.15 121.15 571,799
Oct 10, 2025 122.52 122.98 120.42 121.71 121.71 339,765
Oct 9, 2025 118.71 124.12 118.71 122.52 122.52 648,338
Oct 8, 2025 119.15 120.03 117.30 118.71 118.71 344,722
Oct 7, 2025 119.81 120.78 117.50 118.64 118.64 402,305
Oct 6, 2025 120.64 120.91 119.17 119.94 119.94 543,684
Oct 3, 2025 120.09 122.14 119.72 120.30 120.30 322,318
Oct 2, 2025 118.14 120.80 117.60 119.94 119.94 452,742
Oct 1, 2025 122.49 124.53 118.10 118.57 118.57 526,973
Sep 30, 2025 118.48 121.47 117.50 121.45 121.45 402,098
Sep 29, 2025 117.56 119.68 116.18 117.62 117.62 358,965
Sep 26, 2025 116.15 117.84 115.72 116.76 116.76 344,999
Sep 25, 2025 118.49 118.99 115.31 116.01 116.01 424,290
Sep 24, 2025 117.93 119.04 116.68 118.77 118.77 332,695
Sep 23, 2025 117.50 119.35 116.50 118.19 118.19 432,571

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Axsome Therapeutics, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at AXSM, per a recent SEC DEF 14A filing. We estimate that the median employee at Axsome Therapeutics, Inc. is paid $487,562.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation